Contributor Disclosures for Alopecia Mucinosa

Role Name Disclosure Details Author  Gervaise L Gerstner, MD, Consulting Staff, Department of Dermatology, Wexler Dermatology Nothing to disclose Details Coauthor  Mark G Lebwohl, MD, Chairman, Department of Dermatology, Mount Sinai School of Medicine Abbott Laboratories Actelion Amgen Astellas Basilea Boehringer-Ingelheim Briston-Myers Squibb Celtic Pharma Centocor Cephalon Chattem DermiPsor Doak DOV Forward Galderma Genentech Genzyme GlaxoSmithKline Graceway Helix BioMedix Isotechnika Ligand Medicis Neosil Novartis OMP Pepgen Pfizer PharmaDerm Roche Stiefel Teva UCB Warner Chilcott Details Medical Editor  Günter Burg, MD, Professor and Chairman Emeritus, Department of Dermatology, University of Zürich School of Medicine, Switzerland Nothing to disclose Details Pharmacy Editor  Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center Nothing to disclose Details Managing Editor  Jeffrey Meffert, MD, Assistant Clinical Professor of Dermatology, Medicine, University of Texas Health Science Center-San Antonio Nothing to disclose Details CME Editor  Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Nothing to disclose Details Chief Editor  Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center Nothing to disclose Details Contributor Disclosure Contributor: Contributor Disclosure: Gervaise L Gerstner, Author  The contributor discloses no conflict of interest.  CONTRIBUTOR DISCLOSURE FORM Contributor Name: Mark G Lebwohl  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Abbott Laboratories Honoraria Consulting   Actelion Honoraria Consulting   Amgen Honoraria Consulting   Astellas Honoraria Consulting   Basilea Honoraria Consulting   Boehringer-Ingelheim Honoraria Consulting   Briston-Myers Squibb Honoraria Consulting   Celtic Pharma Honoraria Other   Centocor Honoraria Consulting   Cephalon Honoraria Consulting   Chattem Honoraria Other   DermiPsor Honoraria Consulting   Doak Honoraria Other   DOV Honoraria Consulting   Forward Honoraria Consulting   Galderma Honoraria Consulting   Genentech Honoraria Consulting   Genzyme Honoraria Consulting   GlaxoSmithKline Honoraria Consulting   Graceway Honoraria Consulting   Helix BioMedix Honoraria Consulting   Isotechnika Honoraria Consulting   Ligand Honoraria Other   Medicis Honoraria Investigator   Neosil Honoraria Consulting   Novartis Honoraria Consulting   OMP Honoraria Other   Pepgen Honoraria Consulting   Pfizer Honoraria Consulting   PharmaDerm Honoraria Other   Roche Honoraria Consulting   Stiefel Honoraria Consulting   Teva Honoraria Consulting   UCB Honoraria Consulting   Warner Chilcott Honoraria Review panel membership   Off label or investigational use of medication CONTRIBUTOR DISCLOSURE FORM Contributor Name: Günter Burg  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication CONTRIBUTOR DISCLOSURE FORM Contributor Name: Michael J Wells  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication Contributor Disclosure Contributor: Contributor Disclosure: Jeffrey Meffert, Managing Editor  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: Joel M Gelfand, CME Editor  The contributor discloses no conflict of interest.  CONTRIBUTOR DISCLOSURE FORM Contributor Name: Dirk M Elston  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication